Type 2 Cardiorenal Syndrome: Prevalence and Correlates in Nigerian Heart Failure Patients. [PDF]
Uchendu DG +4 more
europepmc +1 more source
Unraveling Acute Cardiorenal Syndrome: Predictors and Consequences in Acute Heart Failure. [PDF]
Aletras G +11 more
europepmc +1 more source
Jingui Shenqi pill ( ) treats cardiorenal syndrome by inhibiting mitogen-activated protein kinase signaling pathway and reducing inflammatory response. [PDF]
Shuyan H +5 more
europepmc +1 more source
Integrative UHPLC-HRMS and computational biology reveal ferroptosis and anoikis targeting by Wenpitongluo decoction in cardiorenal syndrome. [PDF]
Mao X +5 more
europepmc +1 more source
Neutrophil percentage-to-albumin ratio mediates the association between life's crucial 9 with cardiorenal syndrome: a secondary data analysis from NHANES. [PDF]
Fang Z, Zhao J, Gong H.
europepmc +1 more source
Ultrafiltration in Elderly Patients with Type 1 Cardiorenal Syndrome: Efficacy and Safety Outcomes.
Xu L, Wang Z, Sun L, Liu B, Li H.
europepmc +1 more source
Epidemiology of Cardiorenal Syndrome
Cardiorenal syndrome is a spectrum of disorders that emphasizes the bidirectional nature of cardiac and kidney injury. Observational and retrospective studies have helped us to understand the prevalence and burden of each of the 5 types of cardiorenal syndromes. Cardiorenal syndrome type 1 is the most common.
Uduman, Junior
exaly +4 more sources
Related searches:
Cardiorenal syndrome (CRS) includes a broad spectrum of diseases within which both the heart and kidneys are involved, acutely or chronically. An effective classification of CRS in 2008 essentially divides CRS in two main groups, cardiorenal and renocardiac CRS, based on primum movens of disease (cardiac or renal); both cardiorenal and renocardiac CRS ...
Claudio Ronco, Luca Di Lullo
exaly +3 more sources
Updates in Cardiorenal Syndrome
Medical Clinics of North America, 2023Cardiorenal syndrome is a term that refers to a collection of disorders involving both the heart and kidneys, encompassing multi-directional pathways between the 2 organs mediated through low arterial perfusion, venous congestion, and neurohormonal activation.
Wendy McCallum, Jeffrey M Testani
exaly +3 more sources

